DINGDANG HEALTH (09886) spent HKD 203,000 to repurchase 245,500 shares on May 28th.
Dingdang Health (09886) announced that on May 28, 2026, the company spent 203,300 Hong Kong dollars to repurchase 245,000 shares at a repurchase price of 0.80-0.86 Hong Kong dollars per share.
DINGDANG HEALTH (09886) announced that on May 28, 2026, the company spent HK$203,300 to repurchase 245,500 shares, with a repurchase price of HK$0.80-0.86 per share.
Related Articles
As of May 28, 2026, S.F. Holding (06936) had repurchased a total of 154 million A-shares of the company.
Beijing Konruns Pharmaceutical (603590.SH): KC1036 will be presented in poster form at the 2026 ASCO meeting for the treatment of advanced thymoma.
Weichai Power (02338): Zhang Bo nominated as independent non-executive director.
As of May 28, 2026, S.F. Holding (06936) had repurchased a total of 154 million A-shares of the company.
Beijing Konruns Pharmaceutical (603590.SH): KC1036 will be presented in poster form at the 2026 ASCO meeting for the treatment of advanced thymoma.
Weichai Power (02338): Zhang Bo nominated as independent non-executive director.
